Pancrelipase (Creon, Pancreaze, Pertzye, Viokace, Zenpep) coverage
Defines medical necessity, prior authorization, dosing limits, step therapy requirements, and coverage duration for pancrelipase products for Commercial and HIM lines of business for treatment of exocrine pancreatic insufficiency.
No material clinical or coverage changes in this revision.
Medical Necessity Criteria
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.